Strategy To Limit Sampling of Antituberculosis Drugs Instead of Determining Concentrations at Two Hours Postingestion in Relation to Treatment Response

Por Akkerman, Onno W., van Altena, Richard, Bolhuis, Mathieu S., van der Werf, Tjip S., Alffenaar, Jan-Willem
Publicado em 2014

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

Por Bolhuis, Mathieu S., Panday, Prashant N., Pranger, Arianna D., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado em 2011

Clarithromycin Significantly Increases Linezolid Serum Concentrations

Por Bolhuis, Mathieu S., van Altena, Richard, Uges, Donald R. A., van der Werf, Tjip S., Kosterink, Jos G. W., Alffenaar, Jan-Willem C.
Publicado em 2010

Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

Por Sturkenboom, Marieke G. G., Akkerman, Onno W., Bolhuis, Mathieu S., de Lange, Wiel C. M., van der Werf, Tjip S., Alffenaar, Jan-Willem C.
Publicado no Antimicrob Agents Chemother (2015)

Determination of Bedaquiline in Human Serum Using Liquid Chromatography-Tandem Mass Spectrometry

Por Alffenaar, Jan-Willem C., Bolhuis, Mathieu, van Hateren, Kai, Sturkenboom, Marieke, Akkerman, Onno, de Lange, Wiel, Greijdanus, Ben, van der Werf, Tjip, Touw, Daan
Publicado no Antimicrob Agents Chemother (2015)